Real questions from health communities, answered with cited research from PubMed and Vellito's article corpus. Plain language, no medical advice. How this works.
Yes, SGLT2 inhibitors are effective for treating heart failure with mildly reduced ejection fraction, reducing heart failure hospitalizations and improving outcomes.
Trofinetide shows symptom improvement in Rett syndrome, with real-world studies showing about 76% of patients experiencing benefits in communication and motor skills.
Yes, finerenone reduces cardiovascular death and worsening heart failure events in patients with heart failure with mildly reduced ejection fraction, based on a network…
Activity pacing interventions show a small but not statistically significant effect on cancer-related fatigue overall, but may significantly help patients undergoing chemotherapy.
Yes, a 52-week structured exercise program significantly improves LVEF (by about 5%) and reduces LDL cholesterol in HFmrEF patients after PCI, beyond standard medications alone.
Traditional Chinese medicine (TCM) external therapies like warming needles and acupressure reduce cancer-related fatigue better than usual care, with warming needles showing the…
Yes, activity pacing can help improve cancer-related fatigue during chemotherapy, especially when combined with cognitive behavioral therapy, based on moderate evidence.
The best exercise dose for cancer-related fatigue in breast cancer survivors is around 730 METs-min/week, with an inverted U-shaped response; effects diminish above 1,100…
Yes, acupuncture appears to significantly improve cancer-related fatigue, with recent meta-analyses showing moderate benefit, though study quality is limited.
From 2011 to 2022, adults with cystic fibrosis saw major improvements in lung function, BMI, and fewer exacerbations, largely due to CFTR modulator therapies like…
Bispecific antibodies and CAR T-cell therapy are two immunotherapies being tested for advanced NSCLC; bispecific antibodies show more clinical progress, while CAR T faces…
Yes, a phase III trial (CALGB 140503) found sublobar resection noninferior to lobectomy for disease-free survival in small peripheral NSCLC ≤2 cm.
PROTACs are not yet available as approved treatments for most oncology conditions, though one specific drug, vepdegestrant, is in clinical trials for advanced breast cancer.
Baricitinib showed limited effectiveness for treating eye inflammation in children with juvenile idiopathic arthritis who did not respond to other standard treatments.
Extracellular vesicles (EVs) are promising biomarkers for neurological disorders and heart disease because they carry molecular signals from the brain and heart into the blood…
The phase 2 ketamine trial for tinnitus was completed but has not yet reported its main results.
Yes, Hadlima (adalimumab) is FDA-approved to treat moderately to severely active polyarticular juvenile idiopathic arthritis in patients aged 2 years and older.
Yes, machine learning models using registry data can predict inactive disease in juvenile idiopathic arthritis with about 70-76% accuracy, but they are not yet ready for routine…
Extracellular vesicles (EVs) act as promising biomarkers for neurological disorders like Alzheimer's and Parkinson's, offering a less invasive way to detect disease signals in…
People with iRBD biomarkers show worse cognitive performance than healthy controls, with higher rates of mild cognitive impairment and neuropsychiatric symptoms.
Yes, pucotenlimab has caused severe adverse reactions, including a fatal case of neuromyelitis optica spectrum disorder (NMOSD) in a patient with cancer.
Animal models for NMOSD include AQP4-peptide immunized mice, passive transfer models, and T-cell-based models, each capturing different aspects of pathogenesis.
Yes, DATSCAN imaging helps diagnose dementia with Lewy bodies by showing reduced dopamine transport in the brain, which supports the diagnosis when other symptoms are unclear.
Yes, machine learning with cfDNA can detect liver cancer at various stages, with sensitivities ranging from 44% for stage I to 99% for stage III and high specificity.
We pull real patient questions from public Reddit health communities (r/AskDocs, r/diabetes, r/menopause, etc.). Each question is rewritten into a generic medical question (no personal details), then answered by an AI using only cited sources from Vellito's article database and PubMed. A second AI independently scores each answer for accuracy and citation fidelity before publication. Answers below the safety threshold or touching emergency, dosing, or pediatric topics are queued for human review and never auto-published.
This is not medical advice. Always speak with your own doctor before making decisions about your health.